A publicly available database, the Kaplan–Meier Plotter (http://www.kmplot.com), suggested the close relation of ABL2 upregulation with dismal progression-free survival (FPS) and overall survival (OS) (Fig. 5P) for GC cases. This evidence concerns the gene ABL2 and gastric cancer.